Literature DB >> 14666707

The role of hyaluronan in mesothelium-induced motility of ovarian carcinoma cells.

Philip M Carpenter1, Anh V Dao.   

Abstract

BACKGROUND: Ovarian carcinoma metastases occur when the malignant cells establish new colonies on the peritoneal surface. This study was undertaken to determine whether mesothelial cell hyaluronan affects tumor cell motility.
MATERIALS AND METHODS: Four ovarian carcinoma cell lines (UCI 101, UCI 107, OC 222 and NIH:OVCAR-3) were allowed to migrate toward cultures of mesothelial cells and different concentrations of hyaluronan. Mesothelial hyaluronan production in the presence of the ovarian carcinoma cells was assayed.
RESULTS: The carcinoma lines showed greater motility toward mesothelial cells than controls, but the increased motility was abolished by hyaluronidase. Co-cultures of mesothelial cells and ovarian carcinoma cell lines produced up to twice as much hyaluronan as mesothelial cells alone. Purified hyaluronan induced dose-dependent and chemotactic motility in all carcinoma lines.
CONCLUSION: These results are evidence that mesothelial hyaluronan is a potential paracrine motility factor for ovarian carcinoma. The presence of mesothelial cells on the peritoneal cavity may encourage the establishment of ovarian carcinoma metastases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14666707

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  8 in total

1.  Inhibition of Functional Hyaluronan-CD44 Interactions in CD133-positive Primary Human Ovarian Carcinoma Cells by Small Hyaluronan Oligosaccharides.

Authors:  Mark G Slomiany; Lu Dai; Lauren B Tolliver; G Daniel Grass; Yiping Zeng; Bryan P Toole
Journal:  Clin Cancer Res       Date:  2009-12-15       Impact factor: 12.531

2.  Peritoneal adhesion and angiogenesis in ovarian carcinoma are inversely regulated by hyaluronan: the role of gonadotropins.

Authors:  Yael Chagit Tzuman; Stav Sapoznik; Dorit Granot; Nava Nevo; Michal Neeman
Journal:  Neoplasia       Date:  2010-01       Impact factor: 5.715

Review 3.  Role of versican, hyaluronan and CD44 in ovarian cancer metastasis.

Authors:  Miranda P Ween; Martin K Oehler; Carmela Ricciardelli
Journal:  Int J Mol Sci       Date:  2011-01-31       Impact factor: 5.923

4.  Up-regulation of CD44 in the development of metastasis, recurrence and drug resistance of ovarian cancer.

Authors:  Yan Gao; Rosemary Foster; Xiaoqian Yang; Yong Feng; Jacson K Shen; Henry J Mankin; Francis J Hornicek; Mansoor M Amiji; Zhenfeng Duan
Journal:  Oncotarget       Date:  2015-04-20

5.  Inhibition of adhesion, proliferation, and invasion of primary endometriosis and endometrial stromal and ovarian carcinoma cells by a nonhyaluronan adhesion barrier gel.

Authors:  Stefan P Renner; Pamela L Strissel; Matthias W Beckmann; Johannes Lermann; Stefanie Burghaus; Janina Hackl; Peter A Fasching; Reiner Strick
Journal:  Biomed Res Int       Date:  2015-02-15       Impact factor: 3.411

6.  Effects of anti-CD44 monoclonal antibody IM7 carried with chitosan polylactic acid-coated nano-particles on the treatment of ovarian cancer.

Authors:  Yizhuo Yang; Xinghui Zhao; Xiuli Li; Zhifeng Yan; Zhongyu Liu; Yali Li
Journal:  Oncol Lett       Date:  2016-11-22       Impact factor: 2.967

Review 7.  The peritoneal "soil" for a cancerous "seed": a comprehensive review of the pathogenesis of intraperitoneal cancer metastases.

Authors:  Justyna Mikuła-Pietrasik; Paweł Uruski; Andrzej Tykarski; Krzysztof Książek
Journal:  Cell Mol Life Sci       Date:  2017-09-27       Impact factor: 9.261

8.  Evaluation of the effects of hyaluronic acid-carboxymethyl cellulose barrier on ovarian tumor progression.

Authors:  Laetitia Picaud; Benoît Thibault; Eliane Mery; Monia Ouali; Alejandra Martinez; Jean-Pierre Delord; Bettina Couderc; Gwenael Ferron
Journal:  J Ovarian Res       Date:  2014-04-16       Impact factor: 4.234

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.